EcoDrugPlus

Toll-Like Receptor 2

Ensembl ID : ENSKMAG00000015282
Gene Symbol: LOC108248293
2 Cross references
213 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020549
Gene Symbol: TAAR1
3 Cross references
392 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020478
Gene Symbol: TAAR1
1 Cross references
400 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020618
Gene Symbol: TAAR1
3 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020552
Gene Symbol: TAAR1
1 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020668
Gene Symbol: TAAR1
2 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020676
Gene Symbol: TAAR1
4 Cross references
399 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020683
Gene Symbol: TAAR1
2 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020692
Gene Symbol: TAAR1
3 Cross references
346 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020560
Gene Symbol: TAAR1
2 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020516
Gene Symbol: TAAR1
1 Cross references
400 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020523
Gene Symbol: TAAR1
1 Cross references
343 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).